WDC
FLGT icon

Woodward Diversified Capital’s Fulgent Genetics FLGT Stock Holding History

Woodward Diversified Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,435
Closed -$1.1M – 219
2021
Q1 		$1.1M Buy
+11,435
New +$1.18M 0.65% 44

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Woodward Diversified Capital's FLGT Position: Q2 2021 in Review

Woodward Diversified Capital sold out of Fulgent Genetics (FLGT) in Q2 2021, closing a stake of 11,435 shares — an estimated $1.1M sold.

Woodward Diversified Capital first reported a position in FLGT in Q1 2021 and held it in 1 quarter. The position peaked at $1.1M in Q1 2021. 254 funds tracked by Wall St. Rank hold FLGT as of Q2 2021.

  • Woodward Diversified Capital reported no remaining Fulgent Genetics position as of Q2 2021 after selling out during the quarter.
  • Woodward Diversified Capital sold 11,435 Fulgent Genetics shares in Q2 2021, an estimated $1.1M.
  • Woodward Diversified Capital first reported a position in Fulgent Genetics in Q1 2021 and held it in 1 quarter.
  • Woodward Diversified Capital's Fulgent Genetics position peaked at $1.1M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2021.

Based on Woodward Diversified Capital's 13F filing for Q2 2021, filed 19 Jul 2021.